for babies to help support the developing immune system and overall gut health
|*||These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.|
YOUR PATIENTS CAN RECEIVE A $5 SAVINGS§ + FREE SHIPPING by using promo code COMFORT at checkout – ONLY at TheGerberStore.com
§Restrictions may apply.
B. lactis helps balance the microbiota
Significant increase in bifidobacteria in stools after 1 month of B. lactis supplementation
Supplementing infants with B. lactis can increase the amount of bifidobacteria in their microbiota, especially in those born by C-section
Study design: An observational study of 122 healthy, breastfed infants delivered vaginally or by C-section. Infants assigned to the test group received breast milk and formula supplemented with the B. lactis probiotics, whereas infants in the control group received breast milk and formula without probiotics. The presence of B. lactis and stool bifidobacteria counts were serum immune markers, and stool IgA was also assessed.
B. lactis increased secretory IgA
B. lactis significantly increased vaccine-specific secretory IgA (sIgA) in infants delivered by C-sections
sIgA is an important antibody that helps to support the developing immune system
Study design: Six-week-old healthy, full-term infants (n=172)
enrolled in a prospective, randomized, double-blind, controlled clinical
trial with 2 groups studied in parallel to a breastfed comparison group.
Formula-fed infants were randomized to partially hydrolyzed whey formula or
the same formula containing 106 CFU of
secretory IgA, calprotectin, lactate, and stool pH were assessed at
baseline, 2 weeks, and 6 weeks. Anti-poliovirus-specific IgA and
anti-rotavirus-specific IgA were assessed at 2 and 6 weeks.
sIgA, secretory immunoglobulin A: CFU, colony-forming unit